EFTA01411427Set 10
2015-05-31202p28,772w
trends are
largely
validated by corporate level guidance across the largest global IOCs (XOM,
CVX, COP, BP, RDS, TOT, ENI, STO), where a 13% reduction to 2015 capital
spend ... Norway State 30%,
Centrica 20%)
Premier 50%, KUFPEC 30%, Tullow
20%)
OMV (50%, CVX 40%, DONG 10%)
(Sonangola 60%, Cobalt 40%)
Bonga SW
Nigeria
DW
Shell
(CVX ... Shell
Anadarko
Shell
BPP
Petrobras
Petrobras
(Eni 50%, Shell 50%)
(XOM 56.25%, Shell 43.75%)
(CVX 20%, XOM 20%, Oando 20%,
Svenska 20%, NPDC 15%, Sasol 5%)
BP (60.5%, BHP Billiton
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01411427.pdf
EFTA01501840Set 10
2012-06-311p109w
Value Original Cost Gain/Loss Accrued Div. Yield
Concentrated & Other Equity
JPM CONT BUFF EC) CVX 06/31/12 99.99 3,000,000.000 2,999,700.00 10610.000.00 (300.00)
80% CONTIN BARRIER ... INITIAL LEVEL-05/13/11 CVX:102.39
J.P.Morgan Page 4 of 10
Confidential Treatment Requested by JPMorgan JPM-SDNY-00026247
Chase
CONFIDENTIAL SDNY_GM_00295445
EFTA01501840
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01501840.pdf
EFTA01502000Set 10
2012-02-291p121w
Value Onginal Cost Gain/Loss Accrued Div. Yield
Concentrated & Other Equity
JPM CONT BUFF EQ CVX 06/31/12 110.07 3,000,000.000 3,302,100.00 3,000,000.00 302,100.00
80% CONTIN ... BARRIER- 10.6%CPN
20% CAP
INITIAL LEVEL-05/13/11 CVX:102.39
48125X-RN-8
J.P.Morgan Account Page 4 o' 1 Consolidated Statement Page 7
Confidential Treatment Requested by JPMorgan
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01502000.pdf
Value Original Cost Gain/Loss Accrued Div. Yield
Concentrated & Other Equity
JPM CONT BUFF EQ CVX 06/31112 100.76 3,000,000.000 3,022.800.00 3.000.000 00 22.80O00
80% CONTIN BARRIER ... INITIAL LEVEL-05113/11 CVX:102.39
48125X-RN-8
JP Morgan Account Page 4 of 11 Consolidated Statement Page 7
Confidential Treatment Requested by JPMorgan JPM-SDNY-00026359
Chase
CONFIDENTIAL
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01501937.pdf
EFTA01501795Set 10
2011-05-011p107w
Value Original Cost Gain/Loss Accrued Div. Yield
Concentrated & Other Equity
JPM CONT BUFF El2 CVX 05/31/12 100.77 3,000,000.000 3,023,100.00 3,000,000.00 23,100.00
80% CONTIN ... BARRIER- 10.6%CPN
20% CAP
INITIAL LEVEL-05/13111 CVX:102 39
48125X-RN-8
JP Morgan Page 4 of 12
Confidential Treatment Requested by JPMorgan JPM-SDNY-00026195
Chase
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01501795.pdf
EFTA01501812Set 10
2011-05-311p107w
Value Original Cost Gain/Loss Accrued Div. Yield
Concentrated & Other Equity
JPM CONT BUFF Ei2 CVX 05/31/12 100.77 3,000,000.000 3,023,100.00 3,000,000.00 23,100.00
80% CONTIN ... BARRIER- 10.6%CPN
20% CAP
INITIAL LEVEL-05/13/11 CVX:102 39
48125X-RN-15
JP Morgan Page 4 of 12
Confidential Treatment Requested by JPMorgan JPM-SDNY-00026213
Chase
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01501812.pdf
EFTA01502067Set 10
2012-04-011p117w
Value Original Cost GaiNless Accrued Div. Yield
Concentrated & Other Equity
JPM CONT BUFF EQ CVX 06/31/12 110.40 3,000000.000 3,312,00000 3.000.000.00 312000.00
80% CONT1N BARRIER ... INITIAL LEVEL-05/13/11 CVX:102.39
48125X-RN-8
JP Morgan Account Page 4 of 11 Consolidated Statement Page 7
Confidential Treatment Requested by JPMorgan JPM-SDNY-00026501
Chase
CONFIDENTIAL
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01502067.pdf